167
Views
17
CrossRef citations to date
0
Altmetric
Original Research

The role of CAT in evaluating the response to treatment of patients with AECOPD

, , , , &
Pages 2849-2858 | Published online: 11 Sep 2018

References

  • AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
  • GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
  • SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
  • CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
  • MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • ZhouAZhouZZhaoYChenPThe recent advances of phenotypes in acute exacerbations of COPDInt J Chron Obstruct Pulmon Dis2017121009101828392685
  • Lopez-CamposJLAgustíAHeterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposalLancet Respir Med20153972973426165134
  • CalverleyPMAnzuetoARDusserDTreatment of exacerbations as a predictor of subsequent outcomes in patients with COPDInt J Chron Obstruct Pulmon Dis2018131297130829719385
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • GrouseLNew studies address urgent need for early COPD diagnosisJ Thorac Dis201241192122295163
  • LutchmedialSMCreedWGMooreAJHow common is airflow limitation in patients with emphysema on CT scan of the chest?Chest2015148117618425539080
  • SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Globalstrategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease (Update 2011) Available from: http://goldcopd.org/
  • BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
  • JonesPWHardingGBerryPDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
  • ZhouZZhouAZhaoYDuanJChenPA comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysisInt J Chron Obstruct Pulmon Dis2018131675168229872285
  • TsiligianniIGvan der MolenTMoraitakiDAssessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)BMC Pulm Med2012122022607459
  • MiravitllesMGarcía-SidroPFernández-NistalACourse of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary diseaseHealth Qual Life Outcomes20131114723987232
  • ChettaAOlivieriDThe COPD Assessment Test in the evaluation of chronic obstructive pulmonary disease exacerbationsExpert Rev Respir Med20126437337522971062
  • MackayAJDonaldsonGCPatelARUsefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbationsAm J Respir Crit Care Med2012185111218122422281834
  • AgustíASolerJJMolinaJIs the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?COPD20129549249822958111
  • Folch AyoraAMacia-SolerLOrts-CortésMIHernándezCSeijas-BabotNComparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter studyChron Respir Dis2018 479972318761645:147997231876164
  • KardosPMokrosISauerRVogelmeierCFHealth status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTAInt J Chron Obstruct Pulmon Dis2018131455146829765213
  • Feliz-RodriguezDZudaireSCarpioCEvolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic valueCan Respir J2013205e92e9724093119
  • TuYHZhangYFeiGHUtility of the CAT in the therapy assessment of COPD exacerbations in ChinaBMC Pulm Med2014144224618290
  • PapaioannouMPitsiouGManikaKCOPD assessment test: a simple tool to evaluate disease severity and response to treatmentCOPD201411548949524766370
  • JonesPWHardingGWiklundITests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitationChest2012142113414022281796
  • HuangWCWuMFChenHCHsuJYTOLD Group, MfW, Group TFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
  • AntusBBartaIHorvathICsiszerERelationship between exhaled nitric oxide and treatment response in COPD patients with exacerbationsRespirology201015347247720210889
  • MargaySMFarhatSKaurSTeliHATo study the efficacy and safety of doxophylline and theophylline in bronchial asthmaJ Clin Diagn Res201594FC05FC08
  • DecramerMDekhuijzenPNTroostersTThe Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial CommitteeEur Respir J200117332933611405507
  • DaiMYQiaoJPXuYHFeiGHRespiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestInt J Chron Obstruct Pulmon Dis2015102257226326527871
  • GiffordSZambonJPOrlandoGRecycling organs – growing tailor-made replacement kidneysRegen Med201510891391526542737
  • GhodsAAKhabiriRRaeisdanaNPredictors of inappropriate hospital stay: experience from IranGlob J Health Sci201473828925948427
  • García-SidroPNavalEMartinez RiveraCThe CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbationsRespir Med2015109121546155226542727
  • KonSSCanavanJLJonesSEMinimum clinically important difference for the COPD Assessment Test: a prospective analysisLancet Respir Med20142319520324621681
  • SmidDEFranssenFMHouben-WilkeSResponsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysisJ Am Med Dir Assoc2017181535827624705
  • AlmaHde JongCJelusicDHealth status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important differenceNPJ Prim Care Respir Med2016261604127597571